However, APIP is discriminated from other ERBB3-binding partners, such as c-Src [48, 49] and p85 subunit of PI3K [50] which also bind to the C-terminal regulatory (CR) domain of ERBB3, enabling its phosphorylation and activation in cancer cells. Here, ERBB3 is linked to cancer.